Cellebrite DI (CLBT) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $20.2 million.
- Cellebrite DI's Income from Continuing Operations rose 10974.88% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.3 million, marking a year-over-year increase of 12408.6%. This contributed to the annual value of -$283.0 million for FY2024, which is 24896.05% down from last year.
- Latest data reveals that Cellebrite DI reported Income from Continuing Operations of $20.2 million as of Q3 2025, which was up 10974.88% from $19.5 million recorded in Q2 2025.
- Cellebrite DI's Income from Continuing Operations' 5-year high stood at $51.9 million during Q4 2021, with a 5-year trough of -$207.1 million in Q3 2024.
- Over the past 5 years, Cellebrite DI's median Income from Continuing Operations value was $7.1 million (recorded in 2022), while the average stood at -$8.8 million.
- In the last 5 years, Cellebrite DI's Income from Continuing Operations surged by 165595.8% in 2021 and then plummeted by 328604.62% in 2024.
- Cellebrite DI's Income from Continuing Operations (Quarter) stood at $51.9 million in 2021, then tumbled by 86.35% to $7.1 million in 2022, then plummeted by 306.94% to -$14.6 million in 2023, then surged by 231.56% to $19.3 million in 2024, then increased by 4.77% to $20.2 million in 2025.
- Its Income from Continuing Operations stands at $20.2 million for Q3 2025, versus $19.5 million for Q2 2025 and $17.4 million for Q1 2025.